Neothermia Announces Bleck to Succeed Tully as President, CEO

Neothermia, a developer and marketer of minimally invasive systems for the diagnosis of breast cancer, announced that Thomas Tully, President and CEO, has informed the Board of Directors of his intention to retire, effective April 1. Tully will be succeeded by Christopher Bleck, currently Executive Vice President, Marketing and Sales.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/03-10-2005/0003161044&EDATE=)